Valuation: Renalytix Plc

Market Cap 1.33Cr 1.19Cr 1.11Cr 1.01Cr 1.9Cr 128.44Cr 1.91Cr 13Cr 5.21Cr 66Cr 5.01Cr 4.9Cr 210.71Cr P/E 2024
-0.45x
P/E 2025 -1.34x
Enterprise Value 1.79Cr 1.6Cr 1.49Cr 1.36Cr 2.55Cr 172.74Cr 2.57Cr 18Cr 7.01Cr 88Cr 6.73Cr 6.59Cr 283.39Cr EV / Sales 2024
1,10,59,330x
EV / Sales 2025 1,24,99,418x
Free-Float
81.69%
Yield 2024 *
-
Yield 2025 -
1 week-2.44%
Current month-1.64%
1 month+11.11%
3 months+122.22%
6 months+207.69%
Current year+1.69%
1 week 5.75
Extreme 5.752
6.3
1 month 5
Extreme 5
6.57
Current year 1.6
Extreme 1.6
6.57
1 year 1.6
Extreme 1.6
10
3 years 1.6
Extreme 1.6
74.9
5 years 1.6
Extreme 1.6
940
10 years 1.6
Extreme 1.6
1,220
Manager TitleAgeSince
Chief Executive Officer 58 15/03/2018
Director of Finance/CFO 68 28/05/2024
President 65 30/04/2024
Director TitleAgeSince
Chairman 62 05/11/2024
Director/Board Member 58 15/03/2018
Chairman 74 -
Date Insider Type Main position Quantity % Market Cap. Importance
13/02/26 Buy

Founder

250 0.0001%
13/02/26 Buy

Chief Financial Officer

500 0.0001%
13/02/26 Buy

Founder

500 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-2.44%-27.27%-88.57% 4.79Cr
+2.59%-1.03%+23.47%+34.85% 24TCr
+3.20%-2.81%+4.36%+1.87% 15TCr
+3.59%-2.29%-9.87%+39.71% 14TCr
-0.29%-3.66%-56.05%-17.77% 6.17TCr
+2.63%+0.55%+14.04%+20.93% 4.91TCr
-1.08%-3.15%-22.50%-21.55% 4.74TCr
+1.80%-2.27%+20.92%+55.17% 4.73TCr
+2.17%-0.46%-7.03%+38.37% 4.43TCr
+2.94%-1.25%+33.51%+64.45% 4.18TCr
Average +1.79%-2.49%-2.64%+12.75% 8.23TCr
Weighted average by Cap. +2.44%-2.98%+3.90%+24.46%

Financials

2024 2025
Net sales 2.29 2.04 1.9 1.73 3.26 220.45 3.28 22.99 8.94 112.51 8.59 8.41 361.66 3 2.68 2.49 2.27 4.27 288.92 4.3 30.13 11.72 147.46 11.26 11.02 473.99
Net income -3.35Cr -2.98Cr -2.78Cr -2.53Cr -4.77Cr -322.2Cr -4.8Cr -34Cr -13Cr -164.45Cr -13Cr -12Cr -528.59Cr -2.04Cr -1.82Cr -1.7Cr -1.54Cr -2.91Cr -196.47Cr -2.93Cr -20Cr -7.97Cr -100.27Cr -7.66Cr -7.49Cr -322.31Cr
Net Debt 38.55L 34.39L 32.04L 29.16L 54.91L 37Cr 55.32L 3.87Cr 1.51Cr 19Cr 1.45Cr 1.42Cr 61Cr 46L 41.04L 38.23L 34.79L 65.52L 44Cr 66.01L 4.62Cr 1.8Cr 23Cr 1.73Cr 1.69Cr 73Cr
Logo Renalytix Plc
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
Employees
46
Date Price Change Volume
05/26/05 GBX 6.000 0.00% 1,89,021
02/26/02 GBX 6.000 0.00% 8,80,986
01/26/01 GBX 6.000 -1.64% 12,00,742
30/26/30 GBX 6.100 +0.83% 23,85,600
29/26/29 GBX 6.050 -1.63% 30,19,439

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENX Stock